Executives On The Move: New Hires In Finance, Science and Leadership At Zimmer, ObsEva And Roche Korea
Former Bristol-Myers Squibb exec takes CFO spot at Zimmer Biomet and Swiss reproductive health company ObsEva to bring on new CMO. Plus Roche Korea oncology head is now CEO of LEO Pharma Korea.
You may also be interested in...
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Executives On The Move: New Choices For Finance Spots At Merz Aesthetics, Spruce Biosciences And Lodo Therapeutics
New CFOs are announced at three companies: MerzPharma Group’s Merz Aesthetics; Spruce Biosciences, a firm focusing on treatments for rare endocrine disorders; and Lodo Therapeutics, which is developing novel therapeutics for undruggable targets.
Sol Barer, founder and former CEO of Celgene, has been appointed chair of Cerecor; he is already chair of Teva, Centrexion Therapeutics and NexImmune. Also, PTC Therapeutics announces promotions and ProBioGen gets a new CEO.